Christopher Gocke

Associate Professor

1992 …2019

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output


Final results of a randomized multicenter phase II study of alvocidib, cytarabine, and mitoxantrone versus cytarabine and daunorubicin (7 + 3) in newly diagnosed high-risk acute myeloid leukemia (AML)

Zeidner, J. F., Foster, M. C., Blackford, A. L., Litzow, M. R., Morris, L. E., Strickland, S. A., Lancet, J. E., Bose, P., Levy, M. Y., Tibes, R., Gojo, I., Gocke, C., Rosner, G., Little, R. F., Wright, J. J., Doyle, L. A., Smith, B. D. & Karp, J., Sep 1 2018, In : Leukemia Research. 72, p. 92-95 4 p.

Research output: Contribution to journalLetter


Pentostatin-induced hypereosinophilia with eosinophilic gastroenteritis

Shouval, R., Duffield, A., Gocke, C., Lee, L. & Brodsky, R. A., Aug 1 2010, In : Leukemia and Lymphoma. 51, 8, p. 1567-1569 3 p.

Research output: Contribution to journalLetter


A fatal clostridium infection in an allogeneic stem cell transplant recipient [3]

Jain, M., Titanji, R., Rapoport, A. P., Wang, W., Gocke, C., Cross, A. & Akpek, G., Sep 1 2005, In : Bone marrow transplantation. 36, 5, p. 455-457 3 p.

Research output: Contribution to journalLetter